← Leaderboards
Thomas A Fleisher
Clinical Center
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Autoimmune Lymphoproliferative Syndrome”
- Scott W Wong · Oregon Health And Science University$10,297,028
- Cornelis P Terhorst · Beth Israel Deaconess Medical Center$8,986,697
- Douglas R Green · Burnham Institute For Medical Research$4,063,750
- Paul M. Lieberman · Wistar Institute$2,638,022
- Steven F Ziegler · Seattle Children'S Hospital$2,407,618
- Jianke Zhang · Thomas Jefferson University$2,364,625
Research focus
Autoimmune Lymphoproliferative SyndromeMutationDefectHuman SubjectClinical ResearchEvaluationGenesT-LymphocyteBaseImmunopathologySyndromeUnited States National Institutes Of HealthSamplingLymphatic DiseasesImmuneB LymphocyteLymphocyteClinical PhenotypeLinkApoptoticApoptosisAutoimmunityRecurrenceInterleukin 2 Receptor Gamma
Grant awards (57)
Mutation Analysis Of Selected Lymphoid Immune Disorders$0
ZIA · FY2017 · CL · contact PI
Mutation Analysis Of Selected Lymphoid Immune Disorders$0
ZIA · FY2016 · CL · contact PI
Mutation Analysis Of Selected Lymphoid Immune Disorders$0
ZIA · FY2015 · CL · contact PI
Immune Evaluation in Patients with Autoimmune Lymphoproliferative Syndrome$0
ZIA · FY2015 · CL · contact PI
Mutation Analysis Of Selected Lymphoid Immune Disorders$0
ZIA · FY2014 · CL · contact PI
Evaluation of patients with ALPS-like syndromes$0
ZIA · FY2014 · CL · contact PI
Immune Evaluation in Patients with Autoimmune Lymphoproliferative Syndrome$0
ZIA · FY2014 · CL · contact PI
Mutation Analysis Of Selected Lymphoid Immune Disorders$0
ZIA · FY2012 · CL · contact PI
Evaluation of patients with ALPS-like syndromes$0
ZIA · FY2012 · CL · contact PI
Immune Evaluation in Patients with Autoimmune Lymphoproliferative Syndrome$0
ZIA · FY2012 · CL · contact PI
Evaluation of patients with ALPS-like syndromes$0
ZIA · FY2010 · CL · contact PI
Immune Evaluation in Patients with Autoimmune Lymphoproliferative Syndrome$0
ZIA · FY2010 · CL · contact PI
Characterization of an apoptotic defect in patients with ALPS Type 3$0
ZIA · FY2010 · CL · contact PI
Mutation Analysis Of Selected Lymphoid Immune Disorders$0
ZIA · FY2010 · CL · contact PI
Mutation Analysis Of Selected Lymphoid Immune Disorders$0
ZIA · FY2009 · CL · contact PI
Characterization of an apoptotic defect in patients with ALPS Type 3$0
ZIA · FY2009 · CL · contact PI
Evaluation of an ALPS-like Patient with a Cytokine Withdrawal Apoptotic Defect$0
ZIA · FY2009 · CL · contact PI
Assessment Of Lymphocytes In Patients With Autoimmune Lymphoproliferative Syndro$0
ZIA · FY2009 · CL · contact PI
Assessment Of Lymphocytes In Patients With Autoimmune Lymphoproliferative Syndro$29,796
Z01 · FY2008 · CL · contact PI
Mutation Analysis Of Selected Lymphoid Immune Disorders$23,837
Z01 · FY2008 · CL · contact PI
Evaluation of an ALPS-like Patient with a Cytokine Withdrawal Apoptotic Defect$17,878
Z01 · FY2008 · CL · contact PI
Characterization of an apoptotic defect in patients with ALPS Type 3$11,919
Z01 · FY2008 · CL · contact PI
Assessment Of Lymphocytes In Patients With Autoimmune Lymphoproliferative Syndro$25,000
Z01 · FY2007 · CL · contact PI
Mutation Analysis Of Selected Lymphoid Immune Disorders$20,000
Z01 · FY2007 · CL · contact PI
Evaluation of an ALPS-like Patient with a Cytokine Withdrawal Apoptotic Defect$9,000
Z01 · FY2007 · CL · contact PI
Characterization of an apoptotic defect in patients with ALPS Type 3$7,000
Z01 · FY2007 · CL · contact PI
Mutation Analysis Of Selected Lymphoid Immune Disorders$0
Z01 · FY2006 · CL · contact PI
Assessment Of Lymphocytes In Patients With Autoimmune Ly$0
Z01 · FY2006 · CL · contact PI
Evaluation of an ALPS-like Patient with a Cytokine Withd$0
Z01 · FY2006 · CL · contact PI
Characterization of an apoptotic defect in patients with$0
Z01 · FY2006 · CL · contact PI
Mutation Analysis Of Selected Lymphoid Immune Disorders$0
Z01 · FY2005 · CL
Characterization of an apoptotic defect in patients with$0
Z01 · FY2005 · CL
Evaluation of an ALPS-like Patient with a Cytokine Withd$0
Z01 · FY2005 · CL
Assessment Of Lymphocytes In Patients With ALPS$0
Z01 · FY2005 · CL
Mutation Analysis Of Selected Lymphoid Immune Disorders$0
Z01 · FY2004 · CL
ALPS-like Patient with Cytokine Withdrawal Apoptotic Def$0
Z01 · FY2004 · CL
Assessment Of Lymphocytes In Patients With Autoimmune Ly$0
Z01 · FY2004 · CL
Mutation Analysis Of Selected Lymphoid Immune Disorders$0
Z01 · FY2003 · CL
Assessment Of Memory B Cells In Immune Disorders$0
Z01 · FY2003 · CL
Assessment Of Lymphocytes In Patients With Autoimmune Ly$0
Z01 · FY2003 · CL
Mutation Analysis Of Selected Lymphoid Immune Disorders$0
Z01 · FY2002 · CL
Development Of A Cellular Immune Function Program$0
Z01 · FY2002 · CL
Assessment Of B220 Expression On Human Lymphocytes$0
Z01 · FY2002 · CL
Assessment Of Memory B Cells In Immune Disorders$0
Z01 · FY2002 · CL
Assessment Of Lymphocytes In Patients With Autoimmune Ly$0
Z01 · FY2002 · CL
Lymphocytes In Autoimmune Lymphoproliferative Syndrome$0
Z01 · FY2001 · CL
Development Of A Cellular Immune Function Program$0
Z01 · FY2001 · CL
Assessment Of B220 Expression On Human Lymphocytes$0
Z01 · FY2001 · CL
Assessment Of Memory B Cells In Immune Disorders$0
Z01 · FY2001 · CL
Mutation Analysis Of Selected Lymphoid Immune Disorders$0
Z01 · FY2001 · CL
Peripheral Blood Monocytes In Myobacterial Infections$0
Z01 · FY2001 · CL
Assessment of Lymphocytes in Patients with Autoimmune Lymphoproliferative Syndro$0
Z01 · FY2000 · CL
ASSESSMENT OF B220 EXPRESSION ON HUMAN LYMPHOCYTES$0
Z01 · FY2000 · CL
ASSESSMENT OF MEMORY B CELLS IN IMMUNE DISORDERS$0
Z01 · FY2000 · CL
Mutation Analysis of Selected Lymphoid Immune Disorders$0
Z01 · FY2000 · CL
Assessment of Hydrogen Peroxide Generation in Neutrophils$0
Z01 · FY2000 · CL
Assessment of Peripheral Blood Monocytes in Patients with Recurrent Mycobacteria$0
Z01 · FY2000 · CL